When a compound has an FDA-approved form, that prescribing information is our gold standard.
Published research from medical journals — the foundation of evidence-based dosing.
Licensed 503B and 503A compounding pharmacies that produce research peptides provide clinical dosing guidance.
Specialized peptide research databases used by clinicians and researchers.
Standard Operating Procedures from licensed wellness clinics and longevity practices.
Primary research sources where new studies are published.
Our data isn't static. We run a continuous audit process to make sure every dose and protocol reflects the latest evidence.
All peptide compounds referenced may be research chemicals not approved by the FDA for human use (except where FDA approval is explicitly noted — e.g., Scenesse® for EPP, Wegovy® for weight management, etc.).
Information is provided solely for educational purposes based on publicly available scientific literature. Individual risks and appropriate use cannot be determined without evaluation by a licensed healthcare provider. Do not begin, modify, or stop any health protocol without consulting a qualified medical professional.
Always verify our information against your own research and your healthcare provider's guidance. We're confident in our methodology, but you should never take any single source — including ours — as absolute truth.
If you find a dose, protocol, or citation that looks wrong, tell us. Every correction makes the tool more reliable for the next person.
Email: research@apexdosing.com
Please include: the peptide, the specific number/claim you're disputing, your source, and (ideally) the primary research we should be citing instead. We respond to every research correction within 48 hours.